phesgo sc pertuzumab (rch) 1200mg and trastuzumab (rch) 600mg in 15ml solution for injection, vials
roche products pty ltd - trastuzumab, quantity: 600 mg; water for injections, quantity: 15 ml; pertuzumab, quantity: 1200 mg - injection, solution - excipient ingredients: methionine; trehalose dihydrate; sucrose; histidine; histidine hydrochloride monohydrate; polysorbate 20; vorhyaluronidase alfa - early breast cancer (ebc),phesgo is indicated in combination with chemotherapy for the:,? neoadjuvant treatment of patients with her2-positive, locally advanced, inflammatory, or early stage breast cancer (either >2 cm in diameter or node positive) as part of a complete treatment regimen for early breast cancer,? adjuvant treatment of patients with her2-positive early breast cancer at high risk of recurrence,select patients for therapy based on a validated test.,metastatic breast cancer (mbc),phesgo is indicated in combination with docetaxel for patients with her2-positive metastatic or locally recurrent unresectable breast cancer, who have not received previous anti-her2 therapy or chemotherapy for their metastatic disease. select patients for therapy based on a validated test.
medicamento biotecnológico
f. hoffmann la roche s.a. - obinutuzumab - obinutuzumab....1000 mg
phesgo 600 mg/600 mg solution for injection
f. hoffmann-la roche ltd grenzacherstrasse 124, ch-4070, basel, switzerland - pertuzumab and trastuzumab - solution for injection - one vial of 10 ml solution contains 600 mg of - pertuzumab and trastuzumab
besponsa powder for concentrate for solution for infusion 1mgvial
pfizer private limited - inotuzumab ozogamicin - powder, for solution - inotuzumab ozogamicin 1mg/vial
phesgo solution
hoffmann-la roche limited - trastuzumab; pertuzumab - solution - 40mg; 80mg - trastuzumab 40mg; pertuzumab 80mg - antineoplastic agents
phesgo solution
hoffmann-la roche limited - trastuzumab; pertuzumab - solution - 60mg; 60mg - trastuzumab 60mg; pertuzumab 60mg - antineoplastic agents
gazyva 1000 mg 40 ml concentrate for solution for infusion
roche (malaysia) sdn. bhd. - obinutuzumab -
gazyva concentrate for solution for infusion 1000mg40ml
roche singapore pte. ltd. - obinutuzumab - infusion, solution concentrate - obinutuzumab 1000 mg/40 ml
perjeta
roche diagnostics gmbh - pertuzumab - concentrate for solution for infusion - 30mg/ml
perjeta 420 mg concentrate for solution for infusion
roche (malaysia) sdn. bhd. - pertuzumab -